Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth Allen Myszkowski currently holds 400,600 shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Allen Myszkowski has been a net seller of ARWR stock. They have purchased $13.3K and sold $23.6M worth of shares.
Kenneth Allen Myszkowski's most recent insider trade was on Mar 6, 2024, when they sold 40,000 shares at $35.19 per share.
Kenneth Allen Myszkowski serves as Executive at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). They have executed 90 insider transactions totaling $23.7M over their tenure at the company.
Kenneth Allen Myszkowski holds the position of Executive at ARROWHEAD PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Kenneth Allen Myszkowski has shown a selling trading pattern, with $13.3K in total purchases and $23.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kenneth Allen Myszkowski was on Jan 6, 2021, when they sold $1.8M worth of ARWR shares. This transaction involved 25,166 shares at $72.63 per share.
Kenneth Allen Myszkowski currently owns 400,600 shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth Allen Myszkowski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth Allen Myszkowski has 90 Form 4 filings on record as an insider at ARROWHEAD PHARMACEUTICALS, INC..
Set alerts for Kenneth Allen Myszkowski and 40,000+ other insiders.